Latigo Biotherapeutics, Inc.NASDAQ: LTGO

Latigo Biotherapeutics Price Target Announced at $36.00/Share by Leerink Partners

· Issued by Latigo Biotherapeutics, Inc.

Ratings actions from Benzinga: https://www.benzinga.com/quote/LTGO/analyst-ratings

(18:47 GMT) Latigo Biotherapeutics Initiated at Outperform by Leerink Partners

Ratings actions from Benzinga: https://www.benzinga.com/quote/LTGO/analyst-ratings

Earlier from Latigo Biotherapeutics

All Latigo Biotherapeutics news releases